Envoy Medical (COCH) Price & Analysis

Compare

66 Followers

COCH Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.21 - $3.99

Previous CloseN/A

Volume61.49K

Average Volume (3M)24.57K

Market Cap

$32.93M

Enterprise Value$53.91M

Total Cash (Recent Filing)$5.29M

Total Debt (Recent Filing)$901.00K

Price to Earnings (P/E)―

Beta0.36

Next Earnings

Nov 24, 2025

EPS Estimate

-0.31

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.32

Shares Outstanding21,520,931

10 Day Avg. Volume12,008

30 Day Avg. Volume24,565

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.64

Enterprise Value/Revenue242.84

Enterprise Value/Gross Profit-92.63

Enterprise Value/Ebitda-2.80

Forecast

1Y Price Target

$7.75

Price Target Upside406.54% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Product DevelopmentThe Acclaim CI, a fully implanted cochlear implant that does not require any external component, has been developed by Envoy.

Regulatory ApprovalThe Acclaim CI received approval for its IDE application with the FDA to begin clinical testing and has already started trials with participants.

Bears Say

Development RisksEnvoy Medical’s devices still have long development and/or commercialization roads ahead, with high risks of clinical trials or commercial failures.

Financial PerformanceRevenue was approximately $0 million, compared to estimates of $0.1 million, leading to a net loss of $9.1 million or EPS of $(0.46).

Envoy Medical News

Envoy Medical Amends Stock Purchase Warrants Agreement

An announcement from Envoy Medical ( ($COCH) ) is now available. Envoy Medical, Inc. announced an amendment to...

11d ago

COCH

Envoy Medical Strengthens Capital with Promissory Note

The latest announcement is out from Envoy Medical ( ($COCH) ). On June 26, 2025, Envoy Medical, Inc....

1M ago

COCH

Envoy Medical Elects Directors and Amends Incentive Plan

Envoy Medical ( ($COCH) ) has provided an announcement. At the annual meeting, Envoy Medical‘s stockholders elected two...

2M ago

COCH

Envoy Medical announces four new patents

Envoy Medical (COCH) announces four new patents. The US Patent & Trademark Office issued Envoy Medical Corporation US...

8M ago

COCH

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

Reports Q3 revenue $56,000 vs. $80,000 last year. “The progress and accomplishments of late have been extremely important...

9M ago

COCH

Envoy Medical announces publication on Acclaim CI

Envoy Medical (COCH) announces a peer-reviewed publication in Otology & Neurotology, discussing early experiences with and highlighting potential...

9M ago

COCH

Envoy Medical receives European patent for modular cochlear implant

Envoy Medical (COCH) announces that the European Patent Office has granted the Company Patent No. 3858425, titled,” Implantable...

9M ago

COCH

Envoy Medical receives FDA approval to initiate study for hearing device

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim...

9M ago

COCH

Envoy Medical supports ITEM Coalition letter to CMS on hearing devices

Envoy Medical (COCH) expresses gratitude to the Independence Through Enhancement of Medicare and Medicaid Coalition and the twelve...

10M ago

COCH

Envoy Medical announces AMA CPT Editorial Panel approved codes for AMEI

Envoy Medical (COCH) announced that the American Medical Association, AMA, Current Procedural Terminology, CPT, Editorial Panel has approved...

10M ago

COCH

Envoy Medical initiated with a Buy at Brookline

Brookline analyst Tyler Bussian initiated coverage of Envoy Medical with a Buy rating and $9 price target Published...

10M ago

COCH

Envoy Medical celebrates one year trading as public company

Envoy Medical commemorates its one-year anniversary trading as a public company. On September 29, 2023, the formerly private...

10M ago

COCH

Envoy Medical investor discusses Apple AirPods Pro 2 hearing aid announcement

Envoy Medical (COCH) highlights an interview with key investor Glen Taylor on Fox Business News “The Claman Countdown”...

11M ago

AAPL

COCH

Envoy Medical Updates Investor Presentation with Forward-Looking Statements

Envoy Medical (COCH) just unveiled an announcement. Envoy Medical, Inc. is presenting its updated Investor Presentation to both...

1y ago

COCH

COCH FAQ

What was Envoy Medical’s price range in the past 12 months?

Envoy Medical lowest stock price was $1.21 and its highest was $3.99 in the past 12 months.

What is Envoy Medical’s market cap?

Envoy Medical’s market cap is $32.93M.

When is Envoy Medical’s upcoming earnings report date?

Envoy Medical’s upcoming earnings report date is Nov 24, 2025 which is in 106 days.

How were Envoy Medical’s earnings last quarter?

Envoy Medical released its earnings results on Jul 31, 2025. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.302 by -$0.018.

Is Envoy Medical overvalued?

According to Wall Street analysts Envoy Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Envoy Medical pay dividends?

Envoy Medical does not currently pay dividends.

What is Envoy Medical’s EPS estimate?

Envoy Medical’s EPS estimate is -0.31.

How many shares outstanding does Envoy Medical have?

Envoy Medical has 21,520,931 shares outstanding.

What happened to Envoy Medical’s price movement after its last earnings report?

Envoy Medical reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.302. Following the earnings report the stock price went down -6.41%.

Which hedge fund is a major shareholder of Envoy Medical?

Currently, no hedge funds are holding shares in COCH

Envoy Medical Stock Smart Score

Neutral

Fundamentals

Return on Equity

1697.39%

Trailing 12-Months

Asset Growth

46.95%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Envoy Medical (COCH) Earnings & Revenues

Historic Earnings Reports

COCH Stock 12 Month Forecast

Average Price Target

$7.75

▲(406.54% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","5":"$5","10":"$10","2.5":"$2.5","7.5":"$7.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.5,5,7.5,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,2.06,2.6799999999999997,3.3,3.92,4.54,5.16,5.779999999999999,6.4,7.02,7.640000000000001,8.26,8.879999999999999,{"y":9.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,1.9253846153846155,2.4107692307692306,2.896153846153846,3.3815384615384616,3.866923076923077,4.352307692307692,4.837692307692308,5.323076923076924,5.808461538461538,6.293846153846154,6.77923076923077,7.264615384615384,{"y":7.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,1.790769230769231,2.1415384615384614,2.4923076923076923,2.8430769230769233,3.1938461538461542,3.5446153846153847,3.8953846153846157,4.246153846153847,4.596923076923078,4.947692307692309,5.298461538461539,5.649230769230769,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.3,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.02,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.67,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.55,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.26,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.66,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.37,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.31,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.5,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.49,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >